Roger Vilardaga1, Elisabet Casellas-Pujol2, Joseph F McClernon3, Kathleen A Garrison4. 1. Department of Psychiatry and Behavioral Sciences, Duke School of Medicine, Erwin Terrace Building II, 2812 Erwin Rd, Box 13, Durham, NC 27705, USA. 2. Department of Psychiatry, Hospital Santa Creu I Sant Pau, Carrer de Sant Quinti, 89, 08041 Barcelona, Spain. 3. Department of Psychiatry and Behavioral Sciences, Duke School of Medicine, 2608 Erwin Road, Suite 300, Durham, NC 27705, USA. 4. Department of Psychiatry, Yale School of Medicine, 1 Church Street, Suite 730, New Haven, CT 06510, USA.
Abstract
PURPOSE OF REVIEW: Smoking remains a leading preventable cause of premature death in the world; thus, developing effective and scalable smoking cessation interventions is crucial. This review uses the Obesity-Related Behavioral Intervention Trials (ORBIT) model for early phase development of behavioral interventions to conceptually organize the state of research of mobile applications (apps) for smoking cessation, briefly highlight their technical and theory-based components, and describe available data on efficacy and effectiveness. RECENT FINDINGS: Our review suggests that there is a need for more programmatic efforts in the development of mobile applications for smoking cessation, though it is promising that more studies are reporting early phase research such as user-centered design. We identified and described the app features used to implement smoking cessation interventions, and found that the majority of the apps studied used a limited number of mechanisms of intervention delivery, though more effort is needed to link specific app features with clinical outcomes. Similar to earlier reviews, we found that few apps have yet been tested in large well-controlled clinical trials, although progress is being made in reporting transparency with protocol papers and clinical trial registration. SUMMARY: ORBIT is an effective model to summarize and guide research on smartphone apps for smoking cessation. Continued improvements in early phase research and app design should accelerate the progress of research in mobile apps for smoking cessation.
PURPOSE OF REVIEW: Smoking remains a leading preventable cause of premature death in the world; thus, developing effective and scalable smoking cessation interventions is crucial. This review uses the Obesity-Related Behavioral Intervention Trials (ORBIT) model for early phase development of behavioral interventions to conceptually organize the state of research of mobile applications (apps) for smoking cessation, briefly highlight their technical and theory-based components, and describe available data on efficacy and effectiveness. RECENT FINDINGS: Our review suggests that there is a need for more programmatic efforts in the development of mobile applications for smoking cessation, though it is promising that more studies are reporting early phase research such as user-centered design. We identified and described the app features used to implement smoking cessation interventions, and found that the majority of the apps studied used a limited number of mechanisms of intervention delivery, though more effort is needed to link specific app features with clinical outcomes. Similar to earlier reviews, we found that few apps have yet been tested in large well-controlled clinical trials, although progress is being made in reporting transparency with protocol papers and clinical trial registration. SUMMARY: ORBIT is an effective model to summarize and guide research on smartphone apps for smoking cessation. Continued improvements in early phase research and app design should accelerate the progress of research in mobile apps for smoking cessation.
Entities:
Keywords:
Mobile health; Mobile technology; ORBIT model; Smartphone apps; Smoking cessation; Tobacco use
Authors: Judson A Brewer; Sarah Mallik; Theresa A Babuscio; Charla Nich; Hayley E Johnson; Cameron M Deleone; Candace A Minnix-Cotton; Shannon A Byrne; Hedy Kober; Andrea J Weinstein; Kathleen M Carroll; Bruce J Rounsaville Journal: Drug Alcohol Depend Date: 2011-07-01 Impact factor: 4.492
Authors: Jonathan B Bricker; Kristin E Mull; Julie A Kientz; Roger Vilardaga; Laina D Mercer; Katrina J Akioka; Jaimee L Heffner Journal: Drug Alcohol Depend Date: 2014-07-17 Impact factor: 4.492
Authors: Santosh Kumar; Wendy J Nilsen; Amy Abernethy; Audie Atienza; Kevin Patrick; Misha Pavel; William T Riley; Albert Shar; Bonnie Spring; Donna Spruijt-Metz; Donald Hedeker; Vasant Honavar; Richard Kravitz; R Craig Lefebvre; David C Mohr; Susan A Murphy; Charlene Quinn; Vladimir Shusterman; Dallas Swendeman Journal: Am J Prev Med Date: 2013-08 Impact factor: 5.043
Authors: Neill Bruce Baskerville; Laura Louise Struik; David Hammond; G Emmanuel Guindon; Cameron D Norman; Robyn Whittaker; Catherine M Burns; Kelly A Grindrod; K Stephen Brown Journal: JMIR Res Protoc Date: 2015-01-19
Authors: L Cambon; P Bergman; Al Le Faou; I Vincent; B Le Maitre; A Pasquereau; P Arwidson; D Thomas; F Alla Journal: BMJ Open Date: 2017-02-24 Impact factor: 2.692
Authors: Minda A Gowarty; Meghan R Longacre; Roger Vilardaga; Nathan J Kung; Ashley E Gaughan-Maher; Mary F Brunette Journal: JMIR Ment Health Date: 2021-07-07
Authors: Chaelin K Ra; Emily T Hébert; Adam C Alexander; Angela Helt; Rachel Moisiuc; Darla E Kendzor; Damon J Vidrine; Rachel K Funk-Lawler; Michael S Businelle Journal: J Med Internet Res Date: 2020-03-09 Impact factor: 5.428
Authors: Sven Kernebeck; Theresa S Busse; Maximilian D Böttcher; Jürgen Weitz; Jan Ehlers; Ulrich Bork Journal: World J Gastroenterol Date: 2020-08-07 Impact factor: 5.742
Authors: Rebecca L Ashare; Steven L Bernstein; Robert Schnoll; Robert Gross; Sheryl L Catz; Patricia Cioe; Kristina Crothers; Brian Hitsman; Stephanie L Marhefka; Jennifer B McClure; Lauren R Pacek; Damon J Vidrine; Roger Vilardaga; Annette Kaufman; E Jennifer Edelman Journal: Nicotine Tob Res Date: 2021-01-22 Impact factor: 5.825